본문으로 건너뛰기
← 뒤로

A Review on Melanoma Brain Metastases.

1/5 보강
Current pharmaceutical design 📖 저널 OA 0% 2024: 0/2 OA 2025: 0/9 OA 2026: 0/39 OA 2024~2026 2026 Vol.32(4) p. 261-266
Retraction 확인
출처

Shrestha S, Cook CM, Parekh J, Mattei J

ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 44.0%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도

📝 환자 설명용 한 줄

Melanoma brain metastases (MBM) are associated with poor prognosis and remain a significant challenge in oncology.

이 논문을 인용하기

↓ .bib ↓ .ris
APA Shrestha S, Cook CM, et al. (2026). A Review on Melanoma Brain Metastases.. Current pharmaceutical design, 32(4), 261-266. https://doi.org/10.2174/0113816128340742250118150157
MLA Shrestha S, et al.. "A Review on Melanoma Brain Metastases.." Current pharmaceutical design, vol. 32, no. 4, 2026, pp. 261-266.
PMID 40017253 ↗

Abstract

Melanoma brain metastases (MBM) are associated with poor prognosis and remain a significant challenge in oncology. In recent years, significant progress has been made in understanding the molecular mechanisms underlying MBM. Advances in targeted therapies, immunotherapies, and stereotactic radiosurgery (SRS) have significantly improved patient survival. This study presents an overview of the current landscape of treatment approaches and emerging modalities for MBM treatment, highlighting recent advancements and future directions for research and clinical practice.

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (3)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반